LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced that it has engaged Deutsche Bank Securities Inc. as its strategic advisor in connection with the company’s ongoing process to explore strategic alternatives in order to maximize value to its stockholders.
